MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis
ConclusionsPBC patients carrying the rs661899 T allele are associated with poor prognosis and adverse outcomes after 1-year UDCA therapy.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Bilirubin | Gastroenterology | Laboratory Medicine | Liver | Liver Disease | Urology & Nephrology